The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,254.00
Ask: 12,256.00
Change: -72.00 (-0.58%)
Spread: 2.00 (0.016%)
Open: 12,324.00
High: 12,406.00
Low: 12,246.00
Prev. Close: 12,318.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar holds firm in cautious trading before Fed meets

Tue, 16th Mar 2021 04:29

* Yen hovers at nine-month lows, euro flat
* Focus on Fed comments about higher bond yields
* Sterling dips ahead of BoE meeting on Thursday
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

(Adds analyst comments; updates prices)
By Kevin Buckland and Sagarika Jaisinghani
TOKYO, March 16 (Reuters) - The U.S. dollar clung to small
gains on Tuesday as caution reigned in currency markets ahead of
major central bank meetings, beginning with a two-day Federal
Reserve gathering due to start later in the global day.
The greenback hovered just off its highest since June versus
the yen and cemented a position around $1.19 per euro
in muted trading.
The firmer tone for the dollar came despite a retreat in
U.S. benchmark yields from the highest levels in more than a
year ahead of the Fed meeting.
Expectations are running low for monetary policymakers to
shift from their accommodative stance despite forecasts of rapid
economic growth in the wake of an accelerating COVID-19 vaccine
roll-out and a $1.9 trillion pandemic relief package.

Investors will pore over whatever the Fed has to say about
the run-up in yields, which have risen on bets that economic
growth and inflation could prompt a faster-than-expected
normalisation of monetary policy.
"It's a very pivotal meeting from that perspective," said
Mayank Mishra, an FX strategist at Standard Chartered Bank in
Singapore.
"The other thing that is being awaited is any decision on
the supplemental leverage ratio (SLR) exemption. We don't expect
any explicit push back on back-end yields, but an extension of
the SLR can offer some relief to the market."
The SLR exemption, a regulatory break that allows big banks
to exclude reserve deposits and Treasuries from capital ratios,
is due to expire on March 31.
The dollar was little changed at 109.170 yen after rising to
a nine-month high of 109.365 on Monday. The Bank of Japan begins
a two-day policy meeting on Thursday, along with an extensive
policy review.
The euro was largely flat at $1.19330, languishing below
$1.20 since March 5. Europe's vaccine roll-out has been hampered
by the suspension of AstraZeneca shots in Germany,
France and other nations amid concerns about possible serious
side effects.
Sterling fell about 0.2% to $1.3871 ahead of a Bank
of England meeting on Thursday, where the central bank is
expected to keep its benchmark interest rate at its historic low
of 0.1% and its bond-buying programme unchanged.
The dollar's index against six major currencies was flat at
91.798 after rising nearly 0.2% on Monday.
The Australian dollar, viewed widely as a liquid
proxy for risk appetite, and the New Zealand dollar were
little changed against the U.S. dollar. The commodity-linked
currencies are on course to post their fourth straight quarterly
gain as commodity prices rebound on bets of economic growth.
Bitcoin, meanwhile, slipped to $54,198.64 following its jump
to a record $61,781.83 on Saturday.

========================================================
Currency bid prices at 0400 GMT
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar $1.1934 $1.1929 +0.04% -2.32% +1.1937 +1.1923
Dollar/Yen 109.1550 109.1200 +0.06% +5.71% +109.2400 +109.1900
Euro/Yen 130.26 130.16 +0.08% +2.63% +130.3900 +130.1400
Dollar/Swiss 0.9266 0.9275 -0.10% +4.74% +0.9279 +0.9266
Sterling/Dollar 1.3869 1.3900 -0.21% +1.53% +1.3903 +1.3867
Dollar/Canadian 1.2478 1.2473 +0.05% -2.00% +1.2487 +1.2468
Aussie/Dollar 0.7752 0.7756 -0.05% +0.77% +0.7755 +0.7742
NZ 0.7195 0.7200 +0.00% +0.26% +0.7205 +0.7195
Dollar/Dollar


All spots
Tokyo spots
Europe spots
Volatilities
Tokyo Forex market info from BOJ



(Reporting by Kevin Buckland in Tokyo and Sagarika Jaisinghani
in Bengaluru; Editing by Christopher Cushing & Simon
Cameron-Moore)

More News
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.